Ionis adds former Alexion CEO Ludwig Hantson to Board, expands equity plan by 9.5M shares

Filed June 8, 2026 · Period ending June 4, 2026 · ~1 min read

Key Changes

• medium

  Ludwig N. Hantson, former Alexion CEO (2017-2021) and Baxalta CEO, joined Ionis' Board on June 4, 2026, bringing 30+ years of biopharma leadership experience to the company's governance.

  Item 5.02 verify on EDGAR →
• medium

  Shareholders approved expanding the 2011 Equity Incentive Plan by 9.5 million shares to 52 million total, increasing the pool for employee compensation and potential shareholder dilution.

  Item 5.07 verify on EDGAR →
• low

  Peter N. Reikes also joined the Board effective June 4, 2026, as previously announced in March 2026, following the company's annual meeting.

  Item 5.02 verify on EDGAR →